I am a biotechnologist and entrepreneur specializing in AI-driven bioprocess development and digital twins. My work focuses on helping biopharma teams accelerate R&D, optimize upstream processes, and ensure regulatory-ready innovation.
With a background spanning R&D, CMC, and GMP manufacturing, I bridge science and AI to deliver practical solutions in AI-powered DoE, cell culture and bioreactor optimization, and CPP/CQA modeling.
I also co-founded AnalysisMode, a deep tech AI company supporting life science organizations and EU-funded projects with advanced modeling and digital twin solutions
Experience
Seniority LevelMid-Senior level
Years of Experience6-10 years
Current StatusActive
Skills
Core skills1
Languages3
Skills
I combine a strong scientific foundation in biotechnology with strategic leadership in AI and digital transformation for bioprocessing. My expertise spans the design and deployment of AI-driven bioprocess models, digital twins, and decision intelligence tools that accelerate development, reduce reliance on wet-lab experimentation, and de-risk scale-up. I have defined strategic roadmaps for biopharma companies, led the creation of SimCell, and built partnerships across industry and academia to translate client needs into scalable solutions. Beyond science and technology, I bring experience in business development, fundraising, and market expansion, positioning organizations for growth while ensuring alignment with regulatory frameworks and industry standards.